These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 22262593

  • 1. When should case-only designs be used for safety monitoring of medical products?
    Maclure M, Fireman B, Nelson JC, Hua W, Shoaibi A, Paredes A, Madigan D.
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():50-61. PubMed ID: 22262593
    [Abstract] [Full Text] [Related]

  • 2. Design considerations in an active medical product safety monitoring system.
    Gagne JJ, Fireman B, Ryan PB, Maclure M, Gerhard T, Toh S, Rassen JA, Nelson JC, Schneeweiss S.
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():32-40. PubMed ID: 22262591
    [Abstract] [Full Text] [Related]

  • 3. Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system.
    Rassen JA, Schneeweiss S.
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():41-9. PubMed ID: 22262592
    [Abstract] [Full Text] [Related]

  • 4. A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies.
    Takeuchi Y, Shinozaki T, Matsuyama Y.
    BMC Med Res Methodol; 2018 Jan 08; 18(1):4. PubMed ID: 29310575
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice.
    Weldeselassie YG, Whitaker HJ, Farrington CP.
    Epidemiol Infect; 2011 Dec 08; 139(12):1805-17. PubMed ID: 21849099
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction.
    Platt R, Carnahan RM, Brown JS, Chrischilles E, Curtis LH, Hennessy S, Nelson JC, Racoosin JA, Robb M, Schneeweiss S, Toh S, Weiner MG.
    Pharmacoepidemiol Drug Saf; 2012 Jan 08; 21 Suppl 1():1-8. PubMed ID: 22262586
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Methodologic challenges to studying patient safety and comparative effectiveness.
    Strom BL.
    Med Care; 2007 Oct 08; 45(10 Supl 2):S13-5. PubMed ID: 17909371
    [Abstract] [Full Text] [Related]

  • 16. Methods in epidemiology: observational study designs.
    DiPietro NA.
    Pharmacotherapy; 2010 Oct 08; 30(10):973-84. PubMed ID: 20874034
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The case-crossover study design in pharmacoepidemiology.
    Delaney JA, Suissa S.
    Stat Methods Med Res; 2009 Feb 08; 18(1):53-65. PubMed ID: 18765504
    [Abstract] [Full Text] [Related]

  • 19. Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review.
    Gault N, Castañeda-Sanabria J, De Rycke Y, Guillo S, Foulon S, Tubach F.
    BMC Med Res Methodol; 2017 Feb 08; 17(1):25. PubMed ID: 28178924
    [Abstract] [Full Text] [Related]

  • 20. Bidirectional case-crossover designs for exposures with time trends.
    Navidi W.
    Biometrics; 1998 Jun 08; 54(2):596-605. PubMed ID: 9629646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.